TGFB1 and neoplasm: It promotes TGF‐β signaling at the tumor–bone interface by proteolytic activation of matrix metallopeptidase 9 (MMP9), thus promoting tumor growth and enhancing osteoclast activation and subsequent bone resorption [119].